Test Price
3,000 AED✅ Home Collection Available
Amyotrophic Lateral Sclerosis (ALS) Panel Genetic Test in UAE | 3000 AED | DHA Licensed
Executive Summary & Core Metrics
✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
✓ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Amyotrophic Lateral Sclerosis (ALS) Panel Genetic Test uses Next-Generation Sequencing (NGS) to simultaneously analyze multiple genes associated with both familial and sporadic ALS. This comprehensive panel identifies pathogenic variants in genes such as SOD1, C9orf72, TARDBP, FUS, and others, providing critical information for accurate diagnosis, prognosis, and genetic counseling. The test is performed on certified platforms with 99.9% diagnostic sensitivity.
| Feature | Our Test (ALS Panel NGS) | Closest Alternative (Single Gene Sanger) |
|---|---|---|
| Precision | 99.9% sensitivity, comprehensive panel | ~95% for targeted mutation |
| Methodology | Next-Generation Sequencing (NGS) on certified platform | Sanger sequencing (single gene) |
| Turnaround Time | 3-4 Weeks | 4-6 Weeks for multiple genes |
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant Medical Geneticist, I emphasize that this ALS genetic panel is a powerful diagnostic aid, but results must be interpreted within the full clinical context, including neurological examination, EMG/NCS findings, and family history. A positive result does not guarantee disease onset, and a negative result does not exclude ALS. Pre- and post-test genetic counseling is highly recommended. Please consult your physician before making any medical decisions.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License 9294403.
Advisory on Medication Management
Do not discontinue, initiate, or adjust any prescribed medication without consulting your treating physician. This genetic test result may influence medication decisions; always discuss results with your healthcare provider.
Exclusion Criteria & Emergency Red Flags
- This test is not intended for patients with acute respiratory distress or severe dysphagia requiring urgent medical intervention.
- Do not collect sample if patient has active uncontrolled coagulopathy; consult the phlebotomy team.
- ER Red Flags: Sudden worsening of limb weakness, respiratory failure, or aspiration pneumonia – seek immediate emergency care, not genetic testing.
Patient FAQ & Clinical Guidance
1. How does this ALS genetic test help in my diagnosis?
This ALS NGS panel identifies pathogenic variants in genes like SOD1, C9orf72, TARDBP, and FUS, which can confirm a genetic cause and guide prognosis and family screening. Clinical correlation with neurological exams and EMG is essential. Genetic counseling is recommended before and after testing.
2. What is the sample collection process in the UAE?
A certified phlebotomist visits your home for a simple blood draw, transported in ISO-certified cold chain, with same-day pickup. You can also provide a dried blood spot on an FTA card. Results are securely shared via our patient portal.
3. How long does it take to receive the ALS genetic test result?
Turnaround time is 3 to 4 weeks to ensure 99.9% accuracy and comprehensive analysis. The final report is accompanied by a telephonic consultation with a specialist geneticist.
UAE Regulatory & Data Privacy Adherence
This test and associated data handling comply with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic information is encrypted, stored securely, and used solely for diagnostic purposes with informed patient consent. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE holds DHA Facility License No. 1143, issued by the Dubai Health Authority.
Clinical & Logistical Metadata
| Test Name | Amyotrophic Lateral Sclerosis (ALS) Panel Genetic Test (NGS) |
| Price (AED) | 3,000 |
| Turnaround Time | 3-4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (3-5 mL in EDTA tube) or dried blood spot (FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) on Illumina platform, targeted gene panel |
| ICD-10-CM Code | G12.21 |
| LOINC Code | 101234-0 |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians